Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

2,610 public trials 494 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy

NCT04014764

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Blood Protein Disorders, +31 more
Locations
  • CBCC Global Research Bakersfield, California, United States
  • Pacific Central Coast Health Centers -- SLO Oncology and Hematology Health Center San Luis Obispo, California, United States
  • Colorado West Healthcare System, dba Grand Valley Oncology Grand Junction, Colorado, United States
  • Ocala Oncology Center Ocala, Florida, United States
View all 20 locations
View Trial Details
Completed

MEDI2228 in Subjects With Relapsed/Refractory Multiple Myeloma

NCT03489525

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Boston, Massachusetts, United States
View Trial Details
Completed

Study to Evaluate the Safety and Efficacy of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myeloma Patients

NCT03464916

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Mayo Clinic Minnesota Rochester, Minnesota, United States
  • Icahn School of Medicine New York, United States
  • University of Pennsylvania, Abramson Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT01989598

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Foothills Hospital Calgary, Alberta, Canada
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Kingston Health Sciences Centre Kingston, Ontario, Canada
View Trial Details
Completed

Study of ACY-1215 in Combination With Lenalidomide, and Dexamethasone in Multiple Myeloma

NCT01583283

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • Sarah Cannon Research Institute Drug Development Unit Nashville, Tennessee, United States
View Trial Details

Related conditions